CUE Cue Biopharma
Company Analysis
Latest News
🟢 Cue Biopharma is trading 5.84% up today with catalyst unconfirmed
Cue Biopharma is trading at $29.89 (+5.84%), with the catalyst unconfirmed. - No verified company-specific announcement is dated August 12, 2026. - The latest...
🔴 Cue Biopharma is trading 5.77% down today with no verified company-specific catalyst identified
Cue Biopharma is trading 5.77% down at $26.61 after no verified company-specific catalyst was identified for August 12, 2026. - Latest official company news...
🟢 Cue Biopharma is trading 5.17% up in pre-market; no verified company-specific catalyst identified
Cue Biopharma is trading 5.17% up in pre-market at $29.70, with no new verified company-specific announcement identified to explain the move. - It rose 8.20%...
🟢 Cue Biopharma is trading 5.6% up in after-hours trading; catalyst remains unconfirmed
Cue Biopharma is trading at $29.82, up +5.61%, while the catalyst remains unconfirmed. - Gained 8.20% during the August 11 regular session before extending...
🟢 Cue Biopharma is trading 12.34% up today — catalyst unconfirmed
Cue Biopharma is trading 12.34% up at $29.32 after no clear company-specific announcement was identified for August 11, 2026. - Investor-relations page lists...
🔴 Cue Biopharma is trading 5.59% down today; immediate catalyst unclear
Cue Biopharma is trading 5.59% down at $25.61, reversing pre-market strength ahead of the expected August 11 earnings report; the immediate catalyst remains...
🟢 Cue Biopharma is trading 5% up in pre-market ahead of expected August 11 earnings report
Cue Biopharma is trading at $28.48, up +5.01% in pre-market, with investors potentially positioning ahead of the expected August 11 earnings report, where...
Cue Biopharma Q2 2026 Earnings Preview: What Analysts Expect on August 11, 2026
For the second quarter of 2026, analysts expect Cue Biopharma to report a consensus loss of $1.38 per share on revenue of $3.0 million, with the current stock...
🟢 Cue Biopharma rises 5.1% — Biotech Sector Rallies on Argenx-Forte M&A Deal
With Biotech (XBI) up 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector is trading higher, with the XBI ETF...
🟢 Cue Biopharma is trading 5.2% up today amid biotech momentum and prior deal optimism
Cue Biopharma is trading 5.2% up today at $27.98, driven by broader biotech sector momentum and lingering optimism from recent corporate developments. • The...
Cue Biopharma Appoints Veteran Life Sciences Executive James Ahlers as New CFO
Cue Biopharma has appointed James Ahlers as its new Chief Financial Officer, effective July 30, 2026. Mr. Ahlers brings extensive financial leadership...
🔴 Cue Biopharma is trading 10.1% down today as it reverses from recent highs amid broader biotech weakness
Cue Biopharma is trading at $27.34 (-10.08%) as it reverses sharply from its July 30 close of $30.40 despite a lack of fresh company-specific news. • The move...
🔴 Cue Biopharma is trading 9.1% down today in a sharp reversal from its recent close
Cue Biopharma is trading at $27.65, down 9.1% today in a sharp reversal from its July 30 close of $30.40, despite a lack of fresh company-specific news. • The...
🔴 Cue Biopharma is trading 9.1% down today with no clear company-specific catalyst
Cue Biopharma is trading at $27.64 (-9.09%) today following a sharp pullback from its July 30 close of $30.40, despite a lack of clear company-specific...
🟢 Cue Biopharma is trading 13.03% up today amid a broader risk-on rebound in biotech and growth stocks
Cue Biopharma is trading at $31.66 (+13.03%) as part of a broader risk-on rebound in equities and the biotechnology sector. • The move aligns with a wider...
🟢 Cue Biopharma is trading 6.8% up today as shares rebound amid a broader market rally
Cue Biopharma is trading 6.8% up at $29.91 as shares rebound from yesterday’s pullback and participate in a broader risk-on move in U.S. equities. • The stock...
🔴 Cue Biopharma is trading 5.6% down today on profit-taking after a recent rally
Cue Biopharma is trading at $28.72 (5.6% down) today as the stock sees profit-taking and a cooling of short-term momentum following a sharp multi-day...
🟢 Cue Biopharma is trading 5.8% up today on short-term trading momentum
Cue Biopharma is trading at $32.00 (+5.79%) in early session action, rebounding from a weak July 28 close. • The move follows a volatile stretch and appears...
🔴 Cue Biopharma is trading 6.7% down today on profit-taking after recent post-split rally
Cue Biopharma is trading 6.7% down at $30.38 as investors lock in gains following a sharp multi-month rally triggered by its April 2026 reverse split. • The...
🔴 Cue Biopharma is trading 5.53% down today following its 1-for-30 reverse stock split on July 23rd
Cue Biopharma is trading 5.53% down today at $31.26 as the stock pulls back. • The decline follows a 1-for-30 reverse stock split that took effect on July 23,...